FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034100892> ?p ?o ?g. }

• W2034100892 abstract "Objectives To compare the effectiveness and safety of rituximab alone or in combination with either methotrexate or leflunomide. Methods 10 European registries submitted anonymised datasets with baseline, 3, 6, 9 and 12-month clinical data from patients who started rituximab. Results 1195 patients were treated with rituximab plus methotrexate, 177 with rituximab plus leflunomide and 505 with rituximab alone. Significantly more patients achieved a European League Against Rheumatism good response at 6 months when treated with rituximab plus leflunomide (29.1%) compared with rituximab plus methotrexate (21.1%) and rituximab alone (19.3%; p=0.02 and p=0.01, respectively). Similar results were observed at 12 months. Adverse events occurred in 10.2%, 13.2% and 13.9% of patients on rituximab plus leflunomide, rituximab plus methotrexate and rituximab alone, respectively. Conclusions Leflunomide is an effective and safe alternative to methotrexate as concomitant treatment with rituximab. Slightly better results were obtained by the combination of rituximab and leflunomide than rituximab and methotrexate, raising the possibility of a synergistic effect of leflunomide and rituximab." @default.
• W2034100892 created "2016-06-24" @default.
• W2034100892 creator A5012009272 @default.
• W2034100892 creator A5021089252 @default.
• W2034100892 creator A5035671675 @default.
• W2034100892 creator A5039628338 @default.
• W2034100892 creator A5043580027 @default.
• W2034100892 creator A5048402348 @default.
• W2034100892 creator A5049547284 @default.
• W2034100892 creator A5057994974 @default.
• W2034100892 creator A5063586848 @default.
• W2034100892 creator A5071926023 @default.
• W2034100892 creator A5074038104 @default.
• W2034100892 creator A5074452337 @default.
• W2034100892 creator A5076651742 @default.
• W2034100892 creator A5089477356 @default.
• W2034100892 date "2011-10-04" @default.
• W2034100892 modified "2023-10-16" @default.
• W2034100892 title "Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration" @default.
• W2034100892 cites W1566364946 @default.
• W2034100892 cites W1973739470 @default.
• W2034100892 cites W1992477419 @default.
• W2034100892 cites W1999663447 @default.
• W2034100892 cites W2024644107 @default.
• W2034100892 cites W2030171189 @default.
• W2034100892 cites W2030855147 @default.
• W2034100892 cites W2076393800 @default.
• W2034100892 cites W2077158310 @default.
• W2034100892 cites W2077671506 @default.
• W2034100892 cites W2097564087 @default.
• W2034100892 cites W2143143301 @default.
• W2034100892 cites W2165459235 @default.
• W2034100892 cites W2402287310 @default.
• W2034100892 cites W2411832526 @default.
• W2034100892 doi "https://doi.org/10.1136/annrheumdis-2011-200003" @default.
• W2034100892 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21972242" @default.
• W2034100892 hasPublicationYear "2011" @default.
• W2034100892 type Work @default.
• W2034100892 sameAs 2034100892 @default.
• W2034100892 citedByCount "64" @default.
• W2034100892 countsByYear W20341008922012 @default.
• W2034100892 countsByYear W20341008922013 @default.
• W2034100892 countsByYear W20341008922014 @default.
• W2034100892 countsByYear W20341008922015 @default.
• W2034100892 countsByYear W20341008922016 @default.
• W2034100892 countsByYear W20341008922017 @default.
• W2034100892 countsByYear W20341008922018 @default.
• W2034100892 countsByYear W20341008922019 @default.
• W2034100892 countsByYear W20341008922020 @default.
• W2034100892 countsByYear W20341008922021 @default.
• W2034100892 countsByYear W20341008922022 @default.
• W2034100892 countsByYear W20341008922023 @default.
• W2034100892 crossrefType "journal-article" @default.
• W2034100892 hasAuthorship W2034100892A5012009272 @default.
• W2034100892 hasAuthorship W2034100892A5021089252 @default.
• W2034100892 hasAuthorship W2034100892A5035671675 @default.
• W2034100892 hasAuthorship W2034100892A5039628338 @default.
• W2034100892 hasAuthorship W2034100892A5043580027 @default.
• W2034100892 hasAuthorship W2034100892A5048402348 @default.
• W2034100892 hasAuthorship W2034100892A5049547284 @default.
• W2034100892 hasAuthorship W2034100892A5057994974 @default.
• W2034100892 hasAuthorship W2034100892A5063586848 @default.
• W2034100892 hasAuthorship W2034100892A5071926023 @default.
• W2034100892 hasAuthorship W2034100892A5074038104 @default.
• W2034100892 hasAuthorship W2034100892A5074452337 @default.
• W2034100892 hasAuthorship W2034100892A5076651742 @default.
• W2034100892 hasAuthorship W2034100892A5089477356 @default.
• W2034100892 hasConcept C126322002 @default.
• W2034100892 hasConcept C197934379 @default.
• W2034100892 hasConcept C198451711 @default.
• W2034100892 hasConcept C203014093 @default.
• W2034100892 hasConcept C2775905006 @default.
• W2034100892 hasConcept C2776036978 @default.
• W2034100892 hasConcept C2777489490 @default.
• W2034100892 hasConcept C2777575956 @default.
• W2034100892 hasConcept C2777703276 @default.
• W2034100892 hasConcept C2779338263 @default.
• W2034100892 hasConcept C2780640218 @default.
• W2034100892 hasConcept C2780653079 @default.
• W2034100892 hasConcept C2781059491 @default.
• W2034100892 hasConcept C71924100 @default.
• W2034100892 hasConcept C98274493 @default.
• W2034100892 hasConceptScore W2034100892C126322002 @default.
• W2034100892 hasConceptScore W2034100892C197934379 @default.
• W2034100892 hasConceptScore W2034100892C198451711 @default.
• W2034100892 hasConceptScore W2034100892C203014093 @default.
• W2034100892 hasConceptScore W2034100892C2775905006 @default.
• W2034100892 hasConceptScore W2034100892C2776036978 @default.
• W2034100892 hasConceptScore W2034100892C2777489490 @default.
• W2034100892 hasConceptScore W2034100892C2777575956 @default.
• W2034100892 hasConceptScore W2034100892C2777703276 @default.
• W2034100892 hasConceptScore W2034100892C2779338263 @default.
• W2034100892 hasConceptScore W2034100892C2780640218 @default.
• W2034100892 hasConceptScore W2034100892C2780653079 @default.
• W2034100892 hasConceptScore W2034100892C2781059491 @default.
• W2034100892 hasConceptScore W2034100892C71924100 @default.
• W2034100892 hasConceptScore W2034100892C98274493 @default.
• W2034100892 hasLocation W20341008921 @default.
• W2034100892 hasLocation W20341008922 @default.
• W2034100892 hasOpenAccess W2034100892 @default.

• next